SCHEMBL3176253

SCHEMBL3176253

Cc1ccc(C2(c3ccccc3O)c3ccccc3N(c3ccccc3)c3ccccc32)c(C)c1

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TP53 P04637 2/20 0.34
TDP1 Q9NUW8 2/20 0.34
NPSR1 Q6W5P4 3/20 0.34
ALDH1A1 P00352 3/20 0.33
KDM4E B2RXH2 2/20 0.33
HSD17B10 Q99714 1/20 0.33
MAPT P10636 3/20 0.33
EGLN1 Q9GZT9 1/20 0.33
LMNA P02545 2/20 0.33
HPGD P15428 1/20 0.33
ALOX15 P16050 1/20 0.33
SMN1; SMN2 Q16637 1/20 0.33
RAB9A P51151 2/20 0.32
CYP1A2 P05177 1/20 0.32
CYP2C19 P33261 1/20 0.32
NPC1 O15118 1/20 0.32
ESR1 P03372 1/20 0.32
ESR2 Q92731 1/20 0.32
PDK2 Q15119 1/20 0.31
ADAMTS5 Q9UNA0 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3199631 0.88 EGLN1 (0.36) NPSR1ALDH1A1EGLN1LMNASMN1; SMN2
SCHEMBL3186198 0.86 ESR1 (0.36) TDP1NPSR1ALDH1A1KDM4EMAPT
SCHEMBL10037546 0.85 ALDH1A1 (0.33) ALDH1A1KDM4EHSD17B10MAPTEGLN1
SCHEMBL3227987 0.84 EGLN1 (0.33) NPSR1ALDH1A1EGLN1HPGDCYP1A2
SCHEMBL3076018 0.78 ALDH1A1 (0.38) NPSR1ALDH1A1KDM4EMAPTEGLN1
SCHEMBL10037385 0.77 KDM4E (0.35) TDP1NPSR1ALDH1A1KDM4EHSD17B10
SCHEMBL3197044 0.75 PDK2 (0.33) ALDH1A1KDM4EHSD17B10MAPTEGLN1
SCHEMBL25880376 0.75 PDK2 (0.43) NPSR1ALDH1A1KDM4EHSD17B10CYP1A2
SCHEMBL27413471 0.75 ALDH1A1 (0.34) TP53NPSR1ALDH1A1KDM4EHSD17B10
SCHEMBL20202064 0.74 ALDH1A1 (0.44) NPSR1ALDH1A1EGLN1HPGDCYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120001537-A1 ORGANIC COMPOUND AND ORGANIC ELECTROLUMINESCENCE DEVICE EMPLOYING THE SAME INDUSTRIAL TECHNOLOGY RESEARCH INSTITUTE (TW) 2012-01-05 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120001537-A1 ORGANIC COMPOUND AND ORGANIC ELECTROLUMINESCENCE DEVICE EMPLOYING THE SAME OR10J3, ORC3, PIEZO1 TP53 2295/4885TDP1 3585/4885NPSR1 3413/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.